These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26924665)
41. Stroma and pancreatic ductal adenocarcinoma: an interaction loop. Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638 [TBL] [Abstract][Full Text] [Related]
42. Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? Rooman I; Real FX Gut; 2012 Mar; 61(3):449-58. PubMed ID: 21730103 [TBL] [Abstract][Full Text] [Related]
43. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma. Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349 [TBL] [Abstract][Full Text] [Related]
44. [The molecular mechanism of the invasion and metastasis in the pancreatic ductal adenocarcinoma]. Satoh K Nihon Rinsho; 2015 Mar; 73 Suppl 3():16-21. PubMed ID: 25856978 [No Abstract] [Full Text] [Related]
45. Cancer-associated fibroblasts in pancreatic adenocarcinoma. Pan B; Liao Q; Niu Z; Zhou L; Zhao Y Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509 [TBL] [Abstract][Full Text] [Related]
46. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
47. The correlations of LMX1A and osteopontin expression to the clinicopathologic stages in pancreatic adenocarcinoma. Tsai WC; Lin CK; Yang YS; Chan DC; Gao HW; Chang FN; Jin JS Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):395-400. PubMed ID: 23165334 [TBL] [Abstract][Full Text] [Related]
48. Pancreatic intraepithelial neoplasia revisited and updated. Sipos B; Frank S; Gress T; Hahn S; Klöppel G Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454 [TBL] [Abstract][Full Text] [Related]
49. [R classification and pancreatic ductal adenocarcinoma--R 0 is R 0]. Munding J; Uhl W; Tannapfel A Z Gastroenterol; 2011 Oct; 49(10):1423-7. PubMed ID: 21964897 [TBL] [Abstract][Full Text] [Related]
50. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Fukushima N; Sato N; Ueki T; Rosty C; Walter KM; Wilentz RE; Yeo CJ; Hruban RH; Goggins M Am J Pathol; 2002 May; 160(5):1573-81. PubMed ID: 12000709 [TBL] [Abstract][Full Text] [Related]
51. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671 [TBL] [Abstract][Full Text] [Related]
52. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats]. Liang S; Yang ZL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598 [TBL] [Abstract][Full Text] [Related]
53. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer. Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320 [TBL] [Abstract][Full Text] [Related]
55. Cystic ductal adenocarcinoma of pancreas: an unusual variant. Gupta N; Krishnan PV; Muzaffar J; Arora A; Anuradha S; Gondal R; Agarwal A; Kar P Trop Gastroenterol; 2006; 27(3):131-3. PubMed ID: 17310557 [TBL] [Abstract][Full Text] [Related]
56. [Clinical characteristics of invasive ductal carcinomas of the pancreas according to the histological differentiation]. Yamaue H Nihon Rinsho; 2006 Jan; 64 Suppl 1():48-51. PubMed ID: 16457220 [No Abstract] [Full Text] [Related]
57. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995 [TBL] [Abstract][Full Text] [Related]
58. New morphological features for grading pancreatic ductal adenocarcinomas. Song JW; Lee JH Biomed Res Int; 2013; 2013():175271. PubMed ID: 23984321 [TBL] [Abstract][Full Text] [Related]
60. Neural invasion in the staging of pancreatic cancer. Pour PM; Bell RH; Batra SK Pancreas; 2003 May; 26(4):322-5. PubMed ID: 12717262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]